Abstract
The influence of food on the pharmacokinetics of the triazole antimycotics fluconazole and itraconazole was investigated in a randomised, parallel group, single dose study in 24 healthy subjects. Each group took either a 100 mg capsule of fluconazole or a 100 mg capsule of itraconazole, pre-prandially or after a light meal or a full meal, in a three-way crossover design. Gastric and intestinal pH were measured with a co-administered radio-telemetric pH capsule, and gastric emptying time of the capsule (GET) was taken as the maximum gastric residence time of drug and food.
The plasma AUC and Cmax of itraconazole were significantly different under the various conditions and the mean AUC was greatest after the full meal. The bioavailability (90% confidence intervals) of itraconazole relative to that after the full meal, was 54% (41–77%) on an empty stomach and 86% (65–102%) after a light meal. The criteria for bioequivalence were not attained. In contrast, the bioavailability (90% CI) of fluconazole relative to the full meal was 110% pre-prandially (100–115%) and 102% after the light meal (88–103%), and the criteria for bioequivalence were attained.
Itraconazole absorption was promoted by low stomach pH, long gastric retention time and a high fat content of the coadministered meal, whereas the pharmacokinetics of fluconazole was relatively insensitive to physiological changes in the gastrointestinal tract.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Walter-Sack I (1990) Nahrungsaufnahme und Resorption von Arzneimitteln aus dem Magen-Darm-Trakt. Akt Ernähr-Med 15: 144–149
Davis SS, Hardy JG, Fara JW (1986) Transit of pharmaceutical dosage forms through the small intestine. Gut 27: 886–892
Heykants J, Van Peer A, Van de Velde V, Van Rooy P, Meuldermans V, Lavrijsen K, Woestenborghs R, Van Cutsem J, Cauwenbergh G (1989) The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32 [Suppl 1]: 67–87
Brammer KW, Tarbit MH (1987) A review of the pharmacokinetics of fluconazole (UK-49, 858) in laboratory animals and man. In: Fronthing RA (ed) Recent trends in the discovery, development and evaluation of antifungal agents. Prous, Barcelona, pp 141–150
Grant SM, Clissold SP (1989) Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycoses. Drugs 37: 310–344
Majoverian P, Ferguson RK, Vlasses PH, Rocci ML, Oren A, Fix JA, Caldwell LJ, Gardner C (1985) Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition. Gastroenterology 89: 392–397
Evans DF, Pye G, Branley R, Clark AG, Dyson TJ, Hardcastle JD (1988) Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29: 1035–1041
Woestenborghs R, Lorreyne W, Heykants J (1987) Determination of itraconazole in plasma and animal tissues by HPLC. J Chromatogr 413: 332–327
Allenmark S, Edebo A, Lindgren K (1990) Determination of itraconazole in serum with HPLC and fluorescence detection. J Chromatogr 532: 203–206
Conover WJ, Iman RL (1981) Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35: 124–129
Grant SM Clissold S (1990) Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39: 877–916
Hardin TC, Graybill JR, Fetchick R, Woestenborghs R, Rinaldi MG, et al (1988) Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 32: 1310–1313
Mayer JH (1987) Motility of the stomach and gastroduodenal junction. In: Johnson LR (ed) Physiology of the gastrointestinal tract. 2nd edn. Raven Press, New York, pp 613–629
Scarpignato C (1990) Gastric emptying measurements in man. In: Scarpignato C, Bianchi Porro G (eds) Clinical investigation of gastric function. Front Gastrointest Res Karger, Basel, pp. 198–246
Blum RA, D'Andrea DT, Florentino BM, Wilton JH, Hilligoss DM, Gardner MJ, et al (1991) Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann Int Med 114: 755–757
British Society for Antimicrobial Chemotherapy Working Party (1992) Antifungal Chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 340: 648–651
Lake-Bakaar G, Tom W, Lake-Bakaar D, Gupta N, Beidas S, Elsakr M, Straus E (1988) Gastropathy and ketoconazole oral-absorption in the acquired immunodeficiency syndrome (AIDS). Ann Int Med 109: 471–473
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zimmermann, T., Yeates, R.A., Laufen, H. et al. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur J Clin Pharmacol 46, 147–150 (1994). https://doi.org/10.1007/BF00199879
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199879